Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unreasonable Group is an international company that supports growth-stage entrepreneurs who are solving some of the world's most pressing challenges, including those in healthcare and life sciences. Through its various initiatives like Unreasonable Impact and Unreasonable Health, the organization provides mentorship, capital, and a global network to help startups scale their impact. While not a traditional biotechnology company with its own drug pipeline, Unreasonable Group acts as a critical catalyst for healthcare innovation by accelerating companies working on medical devices, digital health, and sustainable biotechnology. The group focuses on ventures that demonstrate both high commercial potential and significant social or environmental impact.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unreasonable.